No connection

Search Results

NVX vs PAMT

NVX
NOVONIX Limited
BEARISH
Price
$0.80
Market Cap
$187.5M
Sector
Industrials
AI Confidence
90%
PAMT
PAMT CORP
BEARISH
Price
$9.45
Market Cap
$197.9M
Sector
Industrials
AI Confidence
90%

Valuation

P/E Ratio
NVX
--
PAMT
--
Forward P/E
NVX
-3.49
PAMT
--
P/B Ratio
NVX
1.05
PAMT
0.94
P/S Ratio
NVX
33.37
PAMT
0.33
EV/EBITDA
NVX
-14.38
PAMT
120.96

Profitability

Gross Margin
NVX
55.49%
PAMT
11.87%
Operating Margin
NVX
-920.61%
PAMT
-29.82%
Profit Margin
NVX
0.0%
PAMT
-8.8%
ROE
NVX
-61.97%
PAMT
-21.56%
ROA
NVX
-12.82%
PAMT
-6.91%

Growth

Revenue Growth
NVX
-10.1%
PAMT
-15.1%
Earnings Growth
NVX
--
PAMT
--

Financial Health

Debt/Equity
NVX
0.62
PAMT
1.62
Current Ratio
NVX
1.07
PAMT
1.23
Quick Ratio
NVX
0.98
PAMT
1.14

Dividends

Dividend Yield
NVX
--
PAMT
--
Payout Ratio
NVX
0.0%
PAMT
0.0%

AI Verdict

NVX BEARISH

NVX exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 3/9 and a catastrophic operating margin of -920.61%. While the company maintains a decent gross margin of 55.49%, this is completely offset by massive operational inefficiencies and a declining revenue growth rate of -10.10%. The stock is trading at an exorbitant Price/Sales ratio of 33.37, indicating a massive valuation disconnect from its current fundamental performance. With a 5-year price collapse of 96.4% and a bearish technical trend, the company appears to be in a speculative death spiral despite a lone analyst's optimistic target price.

Strengths
Strong Gross Margin (55.49%) suggesting product value
Price/Book ratio near 1.05 indicates trading close to asset value
Manageable Debt/Equity ratio of 0.62
Risks
Extreme operational losses (Operating Margin -920.61%)
Negative revenue growth (-10.10% YoY)
Weak Piotroski F-Score (3/9) indicating deteriorating financial health
PAMT BEARISH

PAMT exhibits severe financial distress, anchored by a weak Piotroski F-Score of 2/9 and a catastrophic year-over-year EPS decline of 369.2%. While the stock appears cheap on a Price-to-Book (0.94) and Price-to-Sales (0.33) basis, these metrics are overshadowed by negative operating margins (-29.82%) and shrinking revenues (-15.10%). The company has transitioned from a period of profitability (2021-2023) into a consistent loss-making cycle with significant earnings misses. The combination of deteriorating fundamentals and a 0/100 technical trend suggests a value trap rather than a value opportunity.

Strengths
Low Price-to-Sales ratio (0.33) suggests significant revenue relative to market cap
Trading slightly below book value (P/B 0.94)
Current ratio of 1.23 indicates adequate short-term liquidity
Risks
Severe earnings collapse with YoY EPS growth of -369.2%
Negative operating margins (-29.82%) indicating an unsustainable cost structure
Consistent revenue contraction (-15.10% YoY and -15.14% Q/Q)

Compare Another Pair

NVX vs PAMT: Head-to-Head Comparison

This page compares NOVONIX Limited (NVX) and PAMT CORP (PAMT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile